Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
48
NCT00952497
A Study of Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric Cancer
Phase: Phase 2
Role: Lead Sponsor
Start: Jun 30, 2009
Completion: Jan 31, 2012